151705-84-9
151705-84-9
Chemical Structure
LCMV gp33-41
Synonym(s): LCMV GP(33-41) M-peptide; gp33 epitope
- CAS No.: 151705-84-9
- Formula:C48H73N11O13S
- Molecular Weight:1044.22
InChIKey: ZEDLVUSFPGQPJT-PGMHYMLFSA-N
SMILES: O=C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC(N)=O)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCSC)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCCN)N
Biological Activity: LCMV gp33-41, the carboxyl-extended 9-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LCMV gp33-41 | 99.56% | LCMV gp33-41, the carboxyl-extended 9-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
